Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo
1998

TC21 Mutations in Breast Cancer

Sample size: 24 publication Evidence: moderate

Author Information

Author(s): KT Barker, MR Crompton

Primary Institution: Institute of Cancer Research

Hypothesis

Are TC21 mutations present in breast carcinomas?

Conclusion

Mutations in TC21 are uncommon in breast carcinomas.

Supporting Evidence

  • Only one breast cancer cell line, CAL51, showed a mutation in TC21.
  • None of the nine primary breast cancer samples analyzed had TC21 mutations.
  • The study confirmed that TC21 mutations are infrequent in breast carcinomas.

Takeaway

The study looked for mutations in a gene called TC21 in breast cancer but found that these mutations are very rare.

Methodology

The study used a single-strand conformational polymorphism (SSCP)-based assay to analyze cDNAs from breast, ovarian, and cervical cancer cell lines and tumors.

Limitations

The study only examined a limited number of breast cancer samples and may not represent all cases.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication